SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000891618-02-003832
Filing Date
2002-08-14
Accepted
2002-08-14 08:56:40
Documents
5
Period of Report
2002-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q f83225e10vq.htm 10-Q 213493
3 EXHIBIT 10.30 f83225exv10w30.txt EX-10.30 24420
4 EXHIBIT 10.31 f83225exv10w31.txt EX-10.31 41855
5 EXHIBIT 10.32 f83225exv10w32.txt EX-10.32 85592
6 EXHIBIT 99.1 f83225exv99w1.txt EX-99.1 1392
  Complete submission text file 0000891618-02-003832.txt   368706
Mailing Address 3832 BAY CENTER PLACE HAYWARD CA 94545
Business Address 3832 BAY CENTER PL HAYWARD CA 94545 5106709300
LYNX THERAPEUTICS INC (Filer) CIK: 0000913275 (see all company filings)

IRS No.: 943161073 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-22570 | Film No.: 02731746
SIC: 2833 Medicinal Chemicals & Botanical Products